- The trend backdrop is active with a 1-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
INCY
MEX
Week ended 24 Jul 2026
Weekly Investor Report
Incyte Corporation · Healthcare · Biotechnology
Latest close
2,036 MXN
-1.5%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 15.4% above the Trend Line and sits at 95.9% of its 52-week range. The latest completed week returned -1.5%, after a 21.5% four-week move. The latest news-sentiment score is 55/100. Near-term considerations: price is close to its 52-week high.
Setup score
69
out of 100
Latest Close
2,036 MXN
24 Jul 2026
1W Return
-1.5%
latest completed week
4W Return
21.5%
short-term follow-through
12W Return
24.0%
quarterly tape
Trend Breadth
53.8%
28 of 52 weeks active
Volume Ratio
12.4x
vs 13-week average
- Next-week expectancy is negative at 11.23% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- 2 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.5%
Latest completed week; four-week move 21.5%.
Indicator stack
33/80
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 11.23%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
55/100
37 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 15.4% above the Trend Line and sits at 95.9% of its 52-week range. The latest completed week returned -1.5%, after a 21.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 12.4x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2212-week average 0.20
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.22Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 21.5% over four weeks, 24.0% over 12 weeks, and 55.9% over one year. The current trend has remained active for 1 consecutive weeks.
Performance by holding period
Active trend streak1 weeks
Active weeks in one year28
Trend breadth53.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.85Latest activity-pressure read.
Pressure change181.7%Four-week change in activity pressure.
Leadership16.07Latest relative-leadership reading.
RS change519.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 37 relevant articles.
12 positive · 22 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-1.5%Distance below the 52-week high.
13-week volatility6.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher3 of 264 weeks finished lower.
Best week+23.3%Week of 10 Jul.
Worst week-5.8%Week of 1 May.
Latest week-1.5%Week of 24 Jul.
Shape of recent returns
Strong gains1
Modest gains2
Flat weeks19
Modest losses3
Sharp losses1
Recent vol6.6%13-week weekly-return volatility.
Base vol4.9%52-week weekly-return volatility.
Up/down split9/10Count of positive and negative weeks in the 52-week window.
Average skew8.9% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorMX Healthcare
4-week rank1 / 78
Group average0.9%
Trend breadth26.9%
Trend26.9%active weekly trend signals
MD61.5%positive activity pressure
RS32.1%positive relative leadership
Four-week leaders
IndustryMX Biotechnology
4-week rank1 / 19
Group average-2.7%
Trend breadth21.1%
Trend21.1%active weekly trend signals
MD52.6%positive activity pressure
RS21.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape62/100
Trend, activity pressure, participation, and risk combine to a 62/100 tape read.
Indicator analysis19/100Latest 12-week confirmation: trend 1/12, activity pressure 2/12, relative leadership 3/12.
Activity pressure 0.22; 2 reversal markers Next-Week ExpectancyNegative 11.23%Next-week expectancy is negative with a 11.23% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment55/100Weighted news tone is neutral across 37 relevant articles.
INCY|Incyte Corp|Price:123.150|Chg%:-3.950 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 2,036 MXN | -1.5% | 1,765 MXN | 1,473 MXN | 0.85 | 16.07 | 9.8K | On |
| 17 Jul 2026 | 2,067 MXN | 0.0% | 1,756 MXN | 1,471 MXN | 0.33 | 18.06 | 0 | Off |
| 10 Jul 2026 | 2,067 MXN | 23.3% | 1,745 MXN | 1,468 MXN | -0.24 | 18.98 | 216 | Off |
| 3 Jul 2026 | 1,676 MXN | 0.0% | 1,738 MXN | 1,465 MXN | -0.85 | -3.77 | 0 | Off |
| 26 Jun 2026 | 1,676 MXN | 0.0% | 1,744 MXN | 1,465 MXN | -1.04 | -3.83 | 0 | Off |
| 19 Jun 2026 | 1,676 MXN | 0.0% | 1,751 MXN | 1,464 MXN | -1.18 | -4.36 | 0 | Off |
| 12 Jun 2026 | 1,676 MXN | 0.0% | 1,758 MXN | 1,464 MXN | -1.36 | -4.60 | 0 | Off |
| 5 Jun 2026 | 1,676 MXN | 0.0% | 1,767 MXN | 1,464 MXN | -1.48 | -1.84 | 0 | Off |
| 29 May 2026 | 1,676 MXN | 2.1% | 1,776 MXN | 1,463 MXN | -1.61 | -4.99 | 27 | Off |
| 22 May 2026 | 1,642 MXN | 0.0% | 1,778 MXN | 1,463 MXN | -1.71 | -6.29 | 0 | Off |
| 15 May 2026 | 1,642 MXN | 0.0% | 1,777 MXN | 1,463 MXN | -1.65 | -5.53 | 0 | Off |
| 8 May 2026 | 1,642 MXN | 0.0% | 1,775 MXN | 1,463 MXN | -1.56 | -7.81 | 0 | Off |
| 1 May 2026 | 1,642 MXN | -5.8% | 1,775 MXN | 1,463 MXN | -1.35 | -5.22 | 199 | Off |
| 24 Apr 2026 | 1,744 MXN | 0.0% | 1,774 MXN | 1,463 MXN | -1.16 | -1.45 | 0 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.